Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle

Arthritis and Rheumatology

Volumn 67, Issue 1, 2015, Pages 266-272

  Mohassel, Payam ^a   Rosen, Paul ^a   Casciola Rosen, Livia ^a   Pak, Katherine ^a   Mammen, Andrew L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; DERMATOMYOSITIS AUTOANTIGEN; MYOGENIN; MYOSIN HEAVY CHAIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION INTERMEDIARY FACTOR 1 GAMMA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRIM33 PROTEIN, HUMAN; TRIM33 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DERMATOMYOSITIS; DOWN REGULATION; HISTOCHEMISTRY; HISTOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BIOPSY; C57BL MOUSE; CELL CULTURE; CELL LINE; HUMAN; INJURIES; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; SKELETAL MYOBLAST;

ANIMALS; BIOMARKERS; BIOPSY; CELL LINE; CELLS, CULTURED; DERMATOMYOSITIS; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; MYOSIN HEAVY CHAINS; REGENERATION; TRANSCRIPTION FACTORS;

EID: 84919946889     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38863     Document Type: Article

References (21)

1. Mammen AL,. Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010; 1184: 134-53.
2. Casciola-Rosen L, Mammen AL,. Myositis autoantibodies. Curr Opin Rheumatol 2012; 24: 602-8.
3. Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O'Callaghan A, Martinez-Gomez X, Bosch X, Labrador-Horrillo M, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 2012; 64: 523-32.
4. Targoff IN, Trieu EP, Levy-Neto M, Prasertsuntarasai T, Miller FW,. Autoantibodies to transcriptional intermediary factor 1γ (TIF1γ) in dermatomyositis [abstract]. Arthritis Rheum 2006; 55 Suppl: S518.
5. Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. Arthritis Rheum 2013; 65: 2954-62.
6. Massague J, Xi Q,. TGF-β control of stem cell differentiation genes. FEBS Lett 2012; 586: 1953-8.
7. Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, et al. A poised chromatin platform for TGF-β access to master regulators. Cell 2011; 147: 1511-24.
8. Hesling C, Lopez J, Fattet L, Gonzalo P, Treilleux I, Blanchard D, et al. Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Development 2013; 140: 167-75.
9. Mammen AL, Casciola-Rosen LA, Hall JC, Christopher-Stine L, Corse AM, Rosen A,. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis Rheum 2009; 60: 3784-93.
10. Casciola-Rosen L,. Autoimmune myositis: new concepts for disease initiation and propagation. Curr Opin Rheumatol 2005; 17: 699-700.
11. Harris JB,. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. Toxicon 2003; 42: 933-45.
12. Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012; 64: 513-22.
13. Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE, Lee J, et al. TIF1γ controls erythroid cell fate by regulating transcription elongation. Cell 2010; 142: 133-43.
14. Bai X, Trowbridge JJ, Riley E, Lee JA, DiBiase A, Kaartinen VM, et al. TiF1-γ plays an essential role in murine hematopoiesis and regulates transcriptional elongation of erythroid genes. Dev Biol 2013; 373: 422-30.
15. Hesling C, Fattet L, Teyre G, Jury D, Gonzalo P, Lopez J, et al. Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells. EMBO Rep 2011; 12: 665-72.
16. Aucagne R, Droin N, Paggetti J, Lagrange B, Largeot A, Hammann A, et al. Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J Clin Invest 2011; 121: 2361-70.
17. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005; 201: 591-601.
18. Jain S, Singhal S, Francis F, Hajdu C, Wang JH, Suriawinata A, et al. Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 2011; 17: 3994-4000.
19. Cai Y, Geutjes EJ, de Lint K, Roepman P, Bruurs L, Yu LR, et al. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes. Oncogene 2014; 33: 2157-68.
20. Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, O'Neil NJ, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet 2012; 44: 1310-5.
21. Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 2014; 343: 152-7.